Vice versa, states of oxidative stress like inflammation or cellular damage, as for example induced by stroke, themselves lead to augmentation of dimethylarginine production via supporting PRMT activity and inhibiting the dimethylarginine dimethylaminohydrolase (DDAH) [18] (see paragraph 4). The gene discussed is DDAH1; the disease is Stroke.